OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Combined Kidney Transplantation
Submission Deadline: July 15, 2020 (Open) Submit Now
Steven Potter, MD, FACS
Division of Abdominal Transplantation, Department of Surgery, Baylor Scott & White Health, USA
Research Interests: renal transplantation; pancreas transplantation; living kidney donation; transplant immunosuppression; urology; urologic oncology
About This Topic
The transplantation of a kidney with another life-saving organ brings both peril and promise. Those with end-organ failure, be it cardiac, pulmonary, or hepatic, are at risk for advancing chronic kidney disease (CKD) and end stage renal failure (ESRD). The challenge for those caring for these transplant candidates, and of course the existential threat posed by disease to those candidates, is assessing the potential risk and benefit calculus in deciding whether transplantation of an individual, extrarenal, organ is best done in candidates with CKD or ESRD in isolation or in combination with a kidney from the same deceased donor. This decision is critical, not only for patients, but for candidates awaiting kidney transplantation alone. Combined solid organ transplants utilizing kidneys with other life saving organs tend to be from disproportionately younger and higher quality deceased donors, and each of these transplants takes a kidney from the pool of transplantable organs that could have saved a kidney-only candidate from a life spent on dialysis. Better data and new approaches will help shed light on the decision analyses for each organ transplant type being combined with a kidney from the same deceased donor, and this will can have a huge impact on the quality of care for those with end stage organ failure awaiting solid organ transplantation.
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.